[ 810659-53-1] BCL-2 INHIBITOR II, YC137

[810659-53-1] BCL-2 INHIBITOR II, YC137

[ 934358-00-6] CASEIN KINASE II INHIBITOR III

[934358-00-6] CASEIN KINASE II INHIBITOR III

[ 403848-57-7] CASPASE-9 INHIBITOR III

[403848-57-7] CASPASE-9 INHIBITOR III

[ 479077-76-4] CIL-102

[479077-76-4] CIL-102

[ 429676-93-7] CATHEPSIN G INHIBITOR I

[429676-93-7] CATHEPSIN G INHIBITOR I

[ 338954-50-0] ETHYL 4,6-DICHLORO-8-METHYLQUINOLINE-3-CARBOXYLATE, 97%

[338954-50-0] ETHYL 4,6-DICHLORO-8-METHYLQUINOLINE-3-CARBOXYLATE, 97%

[ 960129-66-2] EXTRACELLULAR DEATH FACTOR TRIFLUOROACETATE SALT

[960129-66-2] EXTRACELLULAR DEATH FACTOR TRIFLUOROACETATE SALT

[ 710323-61-8] GSK-3 INHIBITOR IX, CONTROL, MEBIO

[710323-61-8] GSK-3 INHIBITOR IX, CONTROL, MEBIO

[ 883973-99-7] FBPASE-1 INHIBITOR

[883973-99-7] FBPASE-1 INHIBITOR

[ 740841-15-0] GSK-3 INHIBITOR X

[740841-15-0] GSK-3 INHIBITOR X

[ 357649-93-5] HISTONE ACETYLTRANSFERASE INHIBITOR IV, CPTH2

[357649-93-5] HISTONE ACETYLTRANSFERASE INHIBITOR IV, CPTH2

[ 926908-04-5] HNHA

[926908-04-5] HNHA

[ 566914-00-9] IL-1R ANTAGONIST

[566914-00-9] IL-1R ANTAGONIST

[ 338949-42-1] LITHIUM TETRA(2-METHYL-8-HYDROXYQUINOLINATO)BORON, 98%

[338949-42-1] LITHIUM TETRA(2-METHYL-8-HYDROXYQUINOLINATO)BORON, 98%

[ 918870-43-6] LCK INHIBITOR II

[918870-43-6] LCK INHIBITOR II

[ 478336-92-4] MIF ANTAGONIST, ISO-1

[478336-92-4] MIF ANTAGONIST, ISO-1

[ 349397-42-8] N,N-DI-N-BUTYL-2-NITROBENZENESULFONAMIDE, 97%

[349397-42-8] N,N-DI-N-BUTYL-2-NITROBENZENESULFONAMIDE, 97%

[ 574715-85-8] N,N-DICYCLOHEXYL-2-FLUOROBENZAMIDE, 97%

[574715-85-8] N,N-DICYCLOHEXYL-2-FLUOROBENZAMIDE, 97%

[ 353785-72-5] N,N-DICYCLOHEXYL-2-METHOXYBENZAMIDE, 97%

[353785-72-5] N,N-DICYCLOHEXYL-2-METHOXYBENZAMIDE, 97%

[ 349090-11-5] N,N-DICYCLOHEXYL-3-METHYLBENZAMIDE, 97%

[349090-11-5] N,N-DICYCLOHEXYL-3-METHYLBENZAMIDE, 97%